SCHEMBL12848456

SCHEMBL12848456

Cn1nnc(N2CCC3=C(C2)c2sc(C(=O)NC4CC=CCC4)nc2CCC3)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12848852 0.82 DNM1L (0.32) —
SCHEMBL12848446 0.82 HPGD (0.37) —
SCHEMBL12848841 0.79 MAPT (0.37) —
SCHEMBL12848559 0.77 TP53 (0.37) —
SCHEMBL12848842 0.63 — —
SCHEMBL4561084 0.56 WDR5 (0.40) —
SCHEMBL12507539 0.55 F10 (0.58) —
SCHEMBL1782420 0.53 IL2 (0.41) —
SCHEMBL14789368 0.51 ATM (0.42) —
SCHEMBL11161552 0.51 ATM (0.42) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110052643-A1 COMPOUNDS FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2011-03-03 — — US disclosed
Send feedback